ImmunoGen, Inc. (IMGN) Announces Webcast of Presentations at Upcoming Investor Conferences  
9/4/2012 10:14:54 AM

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

•Stifel Nicolaus 2012 Healthcare Conference

10:55 am ET on September 5, 2012 in Boston, MA

Presenter: Gregory Perry, Executive Vice President and CFO